IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Development of Method of Fructose Identification in Urine to Detect the Viral Infection
This study has been completed.
Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01638312
First received: January 20, 2012
Last updated: September 3, 2015
Last verified: September 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 20 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.
| Condition |
|---|
| Human Immunodeficiency Virus |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage |
Resource links provided by NLM:
Further study details as provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
Primary Outcome Measures:
- Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform [ Time Frame: Participants provided urine samples once ]
This detection technique, after a viral infection caused by the use of cell pathological changes and urine metabolic waste - fructose concentration, derivatives.Health News voltage changes to detect viral pathogens of activity and virulence. Because viral infection caused by the voltage change has its typical, So you can use voltage measurements to calibrate the presence and activity of a viral infection.
1.How to interpretation the data The gap between values on X-axis is σ, and 50 is a reference to the center position. For example, the sample maybe contain with HIV virus if σ≧10 units.
σ≧10 abnormal positive (+) σ＜10 normal negative (-)
Biospecimen Retention: None Retained
urine
| Enrollment: | 50 |
| Study Start Date: | June 2011 |
| Study Completion Date: | May 2013 |
| Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
HIV infection patient and health people
The study does not have intervention
|
Detailed Description:
The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage.
Eligibility| Ages Eligible for Study: | Child, Adult, Senior |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
the person who has HIV infection
Criteria
Inclusion Criteria:
- HIV infection
Exclusion Criteria:
- who are in highly active antiretroviral therapy(HARRT) therapy
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01638312
Please refer to this study by its ClinicalTrials.gov identifier: NCT01638312
Locations
| Taiwan | |
| Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital | |
| Kaohsiung, Taiwan, 807 | |
Sponsors and Collaborators
Kaohsiung Medical University Chung-Ho Memorial Hospital
Investigators
| Principal Investigator: | JihJin Tsai, MD | The Medicines Company |
More Information
| Responsible Party: | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT01638312 History of Changes |
| Other Study ID Numbers: |
KMUH-IRB-20110188 |
| Study First Received: | January 20, 2012 |
| Results First Received: | February 10, 2015 |
| Last Updated: | September 3, 2015 |
Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
|
HIV, fructose |
Additional relevant MeSH terms:
|
Acquired Immunodeficiency Syndrome HIV Infections Immunologic Deficiency Syndromes Virus Diseases Immune System Diseases Lentivirus Infections |
Retroviridae Infections RNA Virus Infections Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on September 21, 2017